MAPT and Alzheimer disease: Neuroinflammation is a key pathological feature of Alzheimer’s disease, and pro-inflammatory cytokines are known to promote hyperphosphorylation of tau, partly through upregulation of tau-kinases such as GSK-3β [41,42,43].